LFVN Lifevantage

LifeVantage to Participate at the Sidoti Micro Cap Conference

LifeVantage to Participate at the Sidoti Micro Cap Conference

SALT LAKE CITY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024.

Mr. Fife and Mr. Aure will meet virtually with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at  or directly .

About LifeVantage Corporation

LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit .

Investor Relations Contact:

Reed Anderson, ICR

(646) 277-1260



EN
07/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid September 16, 2025 to all stockholders of record at the close of business on September 8, 2025. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a...

 PRESS RELEASE

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Resul...

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Results on September 4, 2025 SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2025, after the stock market closes on Thursday, September 4, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) tha...

 PRESS RELEASE

LifeVantage To Open Iceland Market

LifeVantage To Open Iceland Market Launch delivers innovative business opportunity and top wellness products to Iceland, marking a bold step in European expansion SALT LAKE CITY, July 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced its upcoming launch into Iceland expected in September. This marks the company’s continued partnership with its field leadership on international expansion and reinforces its commitment to delivering science-backed wellness so...

 PRESS RELEASE

LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1...

LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡ Expanded U.S.-clinical research study shows strong results including increased fat loss, improved cravings control, and healthier body composition*‡ SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new results from its second human clinical study on the , revealing even more compelling ou...

 PRESS RELEASE

LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campai...

LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign and Incentive to Drive Global Growth SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its global Activate 2025 virtual event on Saturday, July 12. The event, supported by Consultant-hosted watch parties and local in-person gatherings, provided a dynamic platform to inspire Consultant business engagement and growth. Activate 2025 also celebrated innovation, reinforcing LifeVan...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch